Australia's life sciences sector is evolving rapidly, from emerging biotech and medtech innovators to established organisations conducting complex clinical trials and expanding into global markets. As regulatory requirements and investor expectations increase, businesses need specialist advice that supports innovation without slowing progress.

Gallagher helps life sciences companies manage risk through every stage of growth. From clinical trials and product development to commercialisation, international expansion and capital events, we arrange insurance and risk management solutions that help protect your people, operations and intellectual property.

Insurance expertise for a complex sector

Life sciences organisations operate in a highly specialised and regulated environment. Clinical development programs, intellectual property protection, product liability, cyber threats and regulatory obligations require specialist expertise and access to the right insurance markets.

Our dedicated life sciences team works with:

  • Biotechnology companies
  • Medical technology companies
  • Digital health companies
  • Clinical-stage and pre-commercial businesses
  • Venture-backed and investor-led organisations
  • Companies preparing for capital raising, IPOs or international growth

We understand the challenges businesses face at every stage of development and can arrange the full spectrum of insurance programs required by the sector through a single specialist team.

Supporting growth through every stage of the lifecycle

Early-stage life sciences companies face unique challenges as they progress from research and development to attracting investment and commercial opportunities. We help organisations identify and manage key risks while building a foundation for sustainable growth.

We can help address:

  • Intellectual property and research asset protection
  • Directors and Officers liability exposures
  • Employment and management liability risks
  • Laboratory operations and business interruption risks
  • Governance and investor requirements

These insurance and risk considerations can help early-stage life sciences companies protect key assets, meet investor expectations and build resilience as they move towards commercial viability.

As organisations progress into clinical development, risk considerations become increasingly complex. From local and multi-country clinical trials to regulatory obligations and participant protection, we can help companies secure appropriate cover and navigate an evolving risk landscape.

Our expertise includes:

  • Clinical trial liability insurance
  • Global and multi-country trial programs
  • Cross-border insurance requirements
  • TGA, regulatory and compliance considerations
  • Manufacturing, storage and transportation risks
  • Contractual and partnership-related exposures

For organisations conducting clinical trials, specialist insurance advice can help navigate local and international requirements while supporting trial continuity and stakeholder confidence.

Bringing products to market introduces new operational, cyber and liability exposures. Whether expanding manufacturing capability, entering new markets or scaling globally, we help organisations manage risk with confidence.

We can help organisations address:

  • Product liability and recall protection risks
  • Cyber and privacy risk management
  • Supply chain and distribution risks
  • Business interruption exposures
  • Mergers, acquisitions and expansion risks
  • Governance and investor requirements

As cyber and privacy exposures grow across the sector, life sciences organisations need risk advice that considers data protection, operational resilience and the insurance implications of increasingly connected health technologies. Beyond insurance placement, we can provide cyber risk management services, maturity assessments and benchmarking capabilities to help organisations strengthen resilience and support investor, stakeholder and regulatory expectations.

Local knowledge, global market access

Our specialist team understands the pace, complexity and opportunities within the life sciences sector. We support biotechnology, medtech and digital health organisations across Australia in navigating clinical trials, TGA requirements, product liability exposures, cyber risks and international expansion challenges. Combining local market expertise, access to global insurance markets and dedicated claims support, we help organisations manage risk and make informed insurance decisions at every stage of the business lifecycle.

Why choose Gallagher

  • Australian life sciences expertise across biotech, medtech and digital health sectors
  • Understanding of TGA requirements, clinical trial obligations and evolving regulatory expectations
  • Local support backed by global market access and multinational program capabilities
  • Cyber risk management, benchmarking and risk advisory services to strengthen organisational resilience

Related & Products Services